Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

KEFUROX

CEFUROXIME SODIUM

Standard Dose
EQ 750MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview KEFUROX is listed in Drugs@FDA under application 062592 (ANDA).

Marketing status: Discontinued Active ingredient CEFUROXIME SODIUM Form and strength INJECTABLE;INTRAVENOUS - EQ 750MG BASE/VIAL Sponsor LILLY Submission history Latest submission status date: 2002-11-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview KEFUROX is listed in Drugs@FDA under application 062592 (ANDA). Marketing status: Discontinued Active ingredient CEFUROXIME SODIUM Form and strength INJECTABLE;INTRAVENOUS - EQ 750MG BASE/VIAL Sponsor LILLY Submission history Latest submission status date: 2002-11-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
KEFUROX (CEFUROXIME SODIUM) | Drug Monograph | MedicHelpline